Multiinstitutional home-therapy trial of recombinant human interleukin-2 and interferon alfa-2 in progressive metastatic renal cell carcinoma. The guidelines development tool, the Practice Guidelines ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback